WXT timeline
Every WXT batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| WXT-2608-P4867 | Sermorelin | 10 Aug 2026 | 2026-Q3 | 8 | 98.33 | 0.51 | 98.74 | +0.41 | |
| WXT-2605-U5824 | GHRP-2 | 31 May 2026 | 2026-Q2 | 1 | 98.83 | n<2 | 99.50 | +0.67 | |
| WXT-2605-B5313 | L-Glutathione (reduced) | 10 May 2026 | 2026-Q3 | 1 | 97.39 | n<2 | 97.87 | +0.48 | |
| WXT-2604-K4076 | Leuprolide | 24 Apr 2026 | 2026-Q3 | 2 | 98.83 | 0.78 | 99.27 | +0.44 | |
| WXT-2604-C4728 | Semaglutide | 05 Apr 2026 | 2026-Q3 | 7 | 97.10 | 1.33 | 97.58 | +0.48 | |
| WXT-2604-M5964 | GHRP-6 | 02 Apr 2026 | 2026-Q2 | 2 | 98.34 | 0.31 | 99.12 | +0.78 | |
| WXT-2603-K3648 | BPC-157 | 14 Mar 2026 | 2026-Q2 | 5 | 97.64 | 0.75 | 98.07 | +0.43 | |
| WXT-2603-D6052 | Pramlintide | 02 Mar 2026 | 2026-Q3 | 1 | 97.87 | n<2 | 98.50 | +0.63 | |
| WXT-2602-G4442 | Semaglutide | 27 Feb 2026 | 2026-Q2 | 2 | 97.80 | 0.27 | 97.92 | +0.12 | |
| WXT-2602-P5658 | BPC-157 | 18 Feb 2026 | 2026-Q1 | 11 | 98.24 | 1.82 | 99.00 | +0.76 | |
| WXT-2602-W4680 | BPC-157 | 16 Feb 2026 | 2026-Q2 | 14 | 98.13 | 1.59 | 98.08 | -0.05 | |
| WXT-2602-F3755 | CJC-1295 with DAC | 03 Feb 2026 | 2026-Q2 | 2 | 98.16 | 0.17 | 98.33 | +0.17 | |
| WXT-2601-P4636 | CJC-1295 (no DAC) | 22 Jan 2026 | 2026-Q1 | 5 | 98.15 | 0.33 | 98.47 | +0.32 | |
| WXT-2601-A4454 | Tesamorelin | 07 Jan 2026 | 2026-Q1 | 8 | 96.65 | 1.55 | 97.28 | +0.63 | |
| WXT-2512-F4804 | Semaglutide | 28 Dec 2025 | 2026-Q2 | 4 | 98.75 | 0.92 | 99.50 | +0.75 | |
| WXT-2512-K4589 | MOTS-c | 16 Dec 2025 | 2026-Q1 | 3 | 97.92 | 1.17 | 98.00 | +0.08 | |
| WXT-2512-P4300 | L-Glutathione (reduced) | 03 Dec 2025 | 2026-Q2 | 1 | 98.07 | n<2 | 98.50 | +0.43 | |
| WXT-2511-N4580 | CJC-1295 (no DAC) | 21 Nov 2025 | 2026-Q1 | 1 | 96.95 | n<2 | 98.46 | +1.51 | |
| WXT-2511-P4848 | MOTS-c | 17 Nov 2025 | 2026-Q2 | 1 | 98.23 | n<2 | 98.89 | +0.66 | |
| WXT-2511-P5160 | Melanotan II | 13 Nov 2025 | 2026-Q1 | 6 | 99.09 | 1.02 | 100.00 | +0.91 | |
| WXT-2511-S5991 | Leuprolide | 12 Nov 2025 | 2026-Q1 | 8 | 98.32 | 0.97 | 98.21 | -0.11 | |
| WXT-2510-B5160 | Ipamorelin | 18 Oct 2025 | 2025-Q4 | 7 | 98.10 | 1.37 | 98.50 | +0.40 | |
| WXT-2509-A5382 | Semaglutide | 24 Sep 2025 | 2025-Q4 | 16 | 98.05 | 1.96 | 98.37 | +0.32 | |
| WXT-2508-T5737 | IGF-1 LR3 | 26 Aug 2025 | 2026-Q1 | 5 | 97.18 | 1.05 | 97.96 | +0.78 | |
| WXT-2508-G4316 | Semaglutide | 25 Aug 2025 | 2025-Q3 | 8 | 98.67 | 1.76 | 98.50 | -0.17 | |
| WXT-2508-E5954 | BPC-157 | 13 Aug 2025 | 2026-Q1 | 6 | 97.91 | 1.65 | 98.25 | +0.34 | |
| WXT-2508-G4016 | IGF-1 LR3 | 10 Aug 2025 | 2025-Q3 | 8 | 96.86 | 1.16 | 97.06 | +0.20 | |
| WXT-2507-R5522 | PT-141 (Bremelanotide) | 23 Jul 2025 | 2025-Q3 | 4 | 99.58 | 0.60 | 99.14 | -0.44 | |
| WXT-2507-N4828 | Semaglutide | 18 Jul 2025 | 2025-Q4 | 7 | 97.43 | 1.15 | 97.73 | +0.30 | |
| WXT-2507-J5534 | TB-500 | 18 Jul 2025 | 2025-Q4 | 13 | 97.92 | 1.56 | 98.54 | +0.62 | |
| WXT-2506-D4780 | Sermorelin | 28 Jun 2025 | 2025-Q3 | 2 | 98.48 | 0.93 | 99.00 | +0.52 | |
| WXT-2506-V4278 | Enclomiphene citrate | 06 Jun 2025 | 2025-Q3 | 1 | 99.32 | n<2 | 99.00 | -0.32 | |
| WXT-2506-M3361 | BPC-157 | 03 Jun 2025 | 2025-Q3 | 7 | 99.16 | 0.92 | 99.53 | +0.37 | |
| WXT-2506-K5484 | TB-500 | 03 Jun 2025 | 2025-Q3 | 2 | 97.92 | 0.17 | 98.19 | +0.27 | |
| WXT-2505-T4814 | Tirzepatide | 30 May 2025 | 2025-Q3 | 4 | 97.83 | 0.40 | 98.50 | +0.67 | |
| WXT-2505-J4008 | N-Acetyl Semax Amide | 29 May 2025 | 2025-Q4 | 5 | 98.18 | 1.51 | 98.50 | +0.32 | |
| WXT-2505-E4164 | Semaglutide | 25 May 2025 | 2025-Q4 | 2 | 97.64 | 0.37 | 98.00 | +0.36 | |
| WXT-2505-P4630 | Semaglutide | 16 May 2025 | 2025-Q4 | 6 | 99.24 | 1.27 | 99.50 | +0.26 | |
| WXT-2505-X5572 | Retatrutide | 09 May 2025 | 2025-Q4 | 3 | 97.35 | 0.64 | 97.87 | +0.52 | |
| WXT-2505-B5419 | Tesamorelin | 09 May 2025 | 2025-Q3 | 1 | 97.09 | n<2 | 97.18 | +0.09 | |
| WXT-2505-M3910 | 5-Amino-1MQ | 04 May 2025 | 2025-Q2 | 10 | 98.51 | 0.87 | 98.65 | +0.14 | |
| WXT-2504-L4924 | Liraglutide | 28 Apr 2025 | 2025-Q3 | 9 | 96.78 | 0.74 | 97.50 | +0.72 | |
| WXT-2502-N5210 | ARA-290 | 21 Feb 2025 | 2025-Q2 | 7 | 99.18 | 1.25 | 99.31 | +0.13 | |
| WXT-2502-U5573 | PT-141 (Bremelanotide) | 16 Feb 2025 | 2025-Q2 | 4 | 98.84 | 1.13 | 99.53 | +0.69 | |
| WXT-2502-F3530 | MK-677 (Ibutamoren mesylate) | 16 Feb 2025 | 2025-Q1 | 4 | 99.48 | 0.38 | 99.57 | +0.09 | |
| WXT-2502-A5571 | TB-500 | 05 Feb 2025 | 2025-Q3 | 11 | 98.29 | 1.65 | 98.58 | +0.29 | |
| WXT-2501-X3943 | Survodutide | 16 Jan 2025 | 2025-Q2 | 6 | 98.02 | 0.95 | 97.91 | -0.11 | |
| WXT-2501-J4559 | BPC-157 | 05 Jan 2025 | 2025-Q1 | 2 | 98.21 | 0.54 | 99.31 | +1.10 | |
| WXT-2412-Y6192 | BPC-157 | 22 Dec 2024 | 2025-Q1 | 13 | 99.54 | 1.37 | 99.90 | +0.36 | SHARED BULK |
| WXT-2411-G3549 | GHRP-6 | 28 Nov 2024 | 2024-Q4 | 10 | 98.96 | 1.20 | 99.03 | +0.07 | |
| WXT-2411-H3906 | Sermorelin | 25 Nov 2024 | 2025-Q1 | 4 | 97.84 | 0.69 | 97.78 | -0.06 | |
| WXT-2411-F5848 | BPC-157 | 17 Nov 2024 | 2024-Q4 | 2 | 98.10 | 0.21 | 98.52 | +0.42 | |
| WXT-2411-F4668 | Tirzepatide | 16 Nov 2024 | 2025-Q2 | 12 | 98.43 | 2.00 | 98.50 | +0.07 | |
| WXT-2411-R5246 | PT-141 (Bremelanotide) | 01 Nov 2024 | 2025-Q1 | 1 | 98.26 | n<2 | 98.42 | +0.16 | |
| WXT-2410-J4589 | Ipamorelin | 30 Oct 2024 | 2024-Q4 | 1 | 97.87 | n<2 | 98.71 | +0.84 | |
| WXT-2410-M3901 | PT-141 (Bremelanotide) | 26 Oct 2024 | 2025-Q1 | 2 | 98.23 | 0.02 | 98.59 | +0.36 | |
| WXT-2410-J4489 | BPC-157 | 06 Oct 2024 | 2024-Q4 | 4 | 98.19 | 0.36 | 98.68 | +0.49 | |
| WXT-2409-Y5240 | CJC-1295 with DAC | 21 Sep 2024 | 2025-Q1 | 2 | 96.84 | 0.33 | 97.53 | +0.69 | |
| WXT-2408-X6472 | BPC-157 | 28 Aug 2024 | 2025-Q1 | 6 | 98.48 | 0.88 | 98.87 | +0.39 | |
| WXT-2408-P5247 | MK-677 (Ibutamoren mesylate) | 02 Aug 2024 | 2024-Q4 | 1 | 99.43 | n<2 | 99.38 | -0.05 | SHARED BULK |
| WXT-2407-A5417 | Retatrutide | 22 Jul 2024 | 2024-Q4 | 6 | 97.38 | 0.89 | 97.46 | +0.08 | |
| WXT-2406-W5390 | Selank | 28 Jun 2024 | 2024-Q3 | 10 | 99.01 | 1.11 | 99.64 | +0.63 | |
| WXT-2404-N4017 | GHRP-2 | 19 Apr 2024 | 2024-Q3 | 6 | 98.68 | 0.90 | 99.06 | +0.38 | |
| WXT-2402-L6189 | Tirzepatide | 17 Feb 2024 | 2024-Q1 | 2 | 96.96 | 0.05 | 97.61 | +0.65 | |
| WXT-2402-B3956 | Tirzepatide | 16 Feb 2024 | 2024-Q3 | 3 | 98.74 | 1.51 | 98.65 | -0.09 | |
| WXT-2402-W3946 | Semax | 06 Feb 2024 | 2024-Q2 | 13 | 98.50 | 1.08 | 98.73 | +0.23 | |
| WXT-2312-M3866 | BPC-157 | 05 Dec 2023 | 2024-Q1 | 2 | 98.14 | 0.31 | 98.27 | +0.13 |